Turning the Tables on a rare, aggressive cancer

As a senior copywriter, took on a myriad of deliverables to support the launch of a drug, LARTRUVO, to treat a rare form of cancer. LARTRUVO was fast-tracked by the FDA based on promising phase 2 results - but phase 3 results didn’t achieve significant outcomes, which ended any possibility for post-launch initiatives. From early campaign ideating and concepting, in-depth market research, involved disease awareness strategizing to various promotional deliverables and tactics, I became knowledgeable about the FDA approval process and how to push creative boundaries that brought awareness to a potential drug that could extend the life for patients who had an overlooked cancer.